Shares of ImmuPharma PLC (LON:IMM) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as low as $9.41. ImmuPharma shares last traded at $9.70, with a volume of 46,479 shares trading hands.
The stock has a market cap of $15.73 million and a price-to-earnings ratio of -1.81. The company’s 50 day simple moving average is GBX 11.25. The company has a debt-to-equity ratio of 1.59, a current ratio of 5.94 and a quick ratio of 5.78.
ImmuPharma Company Profile (LON:IMM)
ImmuPharma plc, a pharmaceutical company, develops drug candidates based on peptide therapeutics to treat serious medical conditions. The company's lead product candidate is the Lupuzor, which has completed Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Read More: What are municipal bonds?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.